D-Lyxose-13C-2

D-Lyxose-13C-2 is the 13C labeled D-Lyxose. D-Lyxose is an endogenous metabolite. D-Lyxose is a rare pentose sugar with significant potential for drug synthesis. D-Lyxose can be used as a starting material for anti-tumor drugs such as alpha galactose ceramide immunostimulants. D-Lyxose can be used as a precursor for L-nucleoside analogs for the development of antiviral drugs. D-Lyxose can be used as a synthetic intermediate for other rare sugars such as L-ribose[1][2].

Product Specifications

CAS Number

[70849-22-8]

UNSPSC

12352211

Target

Drug Intermediate; Endogenous Metabolite; Isotope-Labeled Compounds

Type

Isotope-Labeled Compounds

Related Pathways

Metabolic Enzyme/Protease; Others

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/d-lyxose-13c-2.html

Solubility

10 mM in DMSO

Smiles

O=[13CH][C@H]([C@H]([C@@H](CO)O)O)O

Molecular Formula

C4 13CH10O5

Molecular Weight

151.12

References & Citations

[1]Kwon HJ, et al. Substrate specificity of a recombinant D-lyxose isomerase from Providencia stuartii for monosaccharides. J Biosci Bioeng. 2010 Jul;110 (1) :26-31. |[2]Cho EA, et al. Characterization of a novel D-lyxose isomerase from Cohnella laevoribosii RI-39 sp. nov. J Bacteriol. 2007 Mar;189 (5) :1655-63.